Discussion
Blinatumomab, a blood cancer treatment, improved kidney function in two people newly diagnosed with ANCA-associated vasculitis (AAV) and rapidly progressive glomerulonephritis (RPGN), or inflammation in the kidney’s filtering units, a study shows. The therapy is designed to promote an interaction between immune T-cells, which can kill other cells, and…